Can Wellbutrin Be Abused?
Yes, Wellbutrin (bupropion) can be abused, though its abuse potential is significantly lower than traditional stimulants and occurs primarily through non-oral routes of administration (intranasal insufflation or intravenous injection) rather than prescribed oral use.
Understanding Bupropion's Abuse Potential
Official Classification and Pharmacology
Bupropion is not a controlled substance 1. However, the FDA drug label explicitly acknowledges abuse potential, noting that controlled studies demonstrated increased motor activity and agitation/excitement in individuals with histories of drug abuse 1. In populations experienced with drugs of abuse, a single 400 mg dose produced mild amphetamine-like activity, though evidence suggests that recommended daily dosages administered in divided oral doses are not likely to be significantly reinforcing to CNS stimulant abusers 1.
Key Distinction: Route of Administration Matters
The critical factor determining abuse risk is the route of administration. When taken orally as prescribed, bupropion demonstrates limited reinforcing effects because oral administration results in markedly slower absorption and does not induce euphoria 2. The FDA label emphasizes that bupropion hydrochloride extended-release tablets are intended for oral use only, and specifically warns that inhalation of crushed tablets or injection has been reported, with seizures and deaths documented when administered intranasally or parenterally 1.
Clinical Evidence of Abuse
Prevalence and Demographics
A 14-year retrospective review of U.S. Poison Centers found 975 bupropion abuse cases, representing 3.3% of single-substance bupropion exposures 3. Abuse prevalence increased by 75% from 2000 to 2012, with the majority of cases (67.4%) occurring in individuals aged 13-29 years 3. Most exposures were ingestions (745 cases), followed by insufflation (166 cases) and parenteral routes (17 cases) 3.
Serious Medical Consequences
Abuse of bupropion carries significant morbidity risk regardless of route:
- Seizures occurred in 33.5% of abuse cases 3, with seizure frequency not significantly different between routes of administration 3
- Tachycardia was present in 57.0% of cases 3
- Other common effects included agitation (20.2%), hallucinations/delusions (14.0%), and tremor (13.1%) 3
- Outcomes were classified as major in 11.4% of cases, with 4 deaths reported 3
- Tissue necrosis, cellulitis, compartment syndrome, and persistent psychosis have been documented with intravenous use 4
High-Risk Populations
Patients with Eating Disorders
Bupropion should be avoided in patients with bulimia nervosa or anorexia nervosa 5. The drug was originally withdrawn from the market in 1986 after increased seizure incidence was noted in bulimic patients 5. Case reports document severe abuse (up to 3,000-4,500 mg/day) in patients with eating disorders who use bupropion to control binge eating and reduce appetite, resulting in grand mal seizures 6.
Substance Use Disorder History
Most reported cases of bupropion abuse involve individuals with histories of polysubstance use disorder 7, 4. The 2016 AACE/ACE obesity guidelines note that weight-loss medications containing bupropion should be used with caution in patients with excessive alcohol use and those at risk for seizures 5.
Clinical Recommendations
Prescribing Precautions
- Screen for eating disorder history (anorexia nervosa, bulimia nervosa) before prescribing—this is a contraindication 5
- Assess substance use disorder history, particularly stimulant abuse
- Educate patients that crushing, snorting, or injecting bupropion is dangerous and can cause seizures and death 1
- Monitor for diversion, particularly in adolescents and young adults
- Consider abuse potential in patients presenting with unexplained seizures who have access to bupropion 6
Seizure Risk Context
The cumulative 2-year seizure risk at maximum recommended doses (≤450 mg/day) is 0.48%, similar to other antidepressants 5. However, this risk increases dramatically with abuse, particularly at supratherapeutic doses.
Bottom Line for Clinical Practice
While bupropion has legitimate therapeutic uses for depression, smoking cessation, and weight management (in combination with naltrexone), clinicians must recognize its abuse potential, particularly in vulnerable populations. The drug's structural similarity to cathinones and amphetamines confers some psychostimulant properties that can be exploited through non-oral routes 8. However, when prescribed appropriately and taken orally as directed, the abuse risk remains low for most patients. The key is careful patient selection, avoiding use in those with eating disorders or active substance use disorders, and maintaining awareness that abuse—while uncommon—does occur and carries serious medical consequences.